Gilson

Executive Summary

Gilson is a stalwart in the life sciences tools industry, with a history dating back to 1957 and a strong reputation for liquid handling, purification, and sample preparation technologies. The company serves pharmaceutical, diagnostic, and research customers globally, providing instruments, consumables, and software that are integral to drug discovery and analytical chemistry. As a private entity headquartered in Middleton, Wisconsin, Gilson benefits from long-standing customer relationships and a diversified product portfolio. While the company operates in a mature and competitive market, its established brand and continuous innovation position it for steady growth. The anticipated rebound in life sciences funding and R&D spending post-2025 downturn could benefit Gilson, as labs reinvest in equipment. Additionally, the growing demand for automation and digital integration in laboratory workflows presents an opportunity for Gilson to expand its software and connectivity solutions. The company's resilience and loyal customer base support a moderate conviction in its near-term performance.

Upcoming Catalysts (preview)

• Q4 2026Launch of Next-Generation Liquid Handling Platform75% success
• TBDStrategic Acquisition in Diagnostics or Automation40% success
• Q2 2027Expansion of Software-as-a-Service (SaaS) Offerings for Lab Data Management60% success